Etrasimod Shows Promise in Moderate to Severe Ulcerative Colitis

(MedPage Today) -- Etrasimod, an investigational selective sphingosine 1-phosphate (S1P) receptor modulator, led to clinically meaningful improvements in patients with moderately to severely active ulcerative colitis (UC), according to an analysis...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news